| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
collagen type IV alpha 1 chain | 0.484 | 0.731 | 1.00 |
|
phenotype | 0.400 | strong | 1.000 | 0 | 1 | 2007 | 2007 | ||||||||
|
phosphoglycerate dehydrogenase | 0.484 | 0.885 | 1.3E-04 |
|
phenotype | 0.110 | None | 1.000 | 0 | 2 | 2000 | 2000 | ||||||||
|
SRY-box transcription factor 4 | 0.489 | 0.808 | 0.93 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
calcium voltage-gated channel subunit alpha1 A | 0.489 | 0.769 | 1.00 |
|
phenotype | 0.200 | None | 0.900 | 0 | 2 | 1997 | 2019 | ||||||||
|
growth hormone receptor | 0.490 | 0.846 | 8.4E-05 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
frizzled class receptor 4 | 0.490 | 0.923 | 0.97 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
cholinergic receptor nicotinic alpha 4 subunit | 0.492 | 0.808 | 8.5E-05 |
|
phenotype | 0.440 | None | 1.000 | 9 | 1 | 1999 | 2019 | ||||||||
|
ATPase copper transporting alpha | 0.494 | 0.769 | 1.00 |
|
phenotype | 0.400 | None | 1.000 | 0 | 1 | 2012 | 2012 | ||||||||
|
SRY-box transcription factor 11 | 0.494 | 0.808 | 0.86 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
collagen type XI alpha 1 chain | 0.495 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
stromal interaction molecule 1 | 0.501 | 0.808 | 0.78 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
AT-rich interaction domain 1B | 0.503 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2012 | 2015 | ||||||||
|
SATB homeobox 2 | 0.503 | 0.769 | 1.00 |
|
phenotype | 0.110 | None | 1.000 | 0 | 1 | 2018 | 2018 | ||||||||
|
platelet activating factor acetylhydrolase 1b regulatory subunit 1 | 0.504 | 0.769 | 1.00 |
|
phenotype | 0.110 | None | 1.000 | 3 | 1 | 1999 | 2003 | ||||||||
|
nuclear receptor binding SET domain protein 1 | 0.505 | 0.769 | 1.00 |
|
phenotype | 0.110 | None | 1.000 | 0 | 1 | 2014 | 2014 | ||||||||
|
structural maintenance of chromosomes 1A | 0.509 | 0.808 | 1.00 |
|
phenotype | 0.420 | strong | 1.000 | 0 | 1 | 2015 | 2019 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2B | 0.510 | 0.692 | 1.00 |
|
phenotype | 0.150 | None | 1.000 | 0 | 2 | 2014 | 2017 | ||||||||
|
sodium voltage-gated channel alpha subunit 8 | 0.510 | 0.731 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 0 | 2 | 2007 | 2019 | ||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
phenotype | 0.110 | None | 1.000 | 0 | 1 | 2013 | 2013 | ||||||||
|
solute carrier family 9 member A6 | 0.516 | 0.846 | 1.00 |
|
phenotype | 0.120 | None | 1.000 | 0 | 2 | 2011 | 2014 | ||||||||
|
aristaless related homeobox | 0.516 | 0.654 | 0.91 |
|
phenotype | 0.150 | None | 0.800 | 0 | 1 | 2007 | 2017 | ||||||||
|
three prime repair exonuclease 1 | 0.517 | 0.808 | 0.58 |
|
phenotype | 0.400 | strong | 1.000 | 1 | 2 | 2008 | 2016 | ||||||||
|
myocyte enhancer factor 2C | 0.517 | 0.769 | 1.7E-02 |
|
phenotype | 0.120 | None | 1.000 | 1 | 3 | 2010 | 2018 | ||||||||
|
sodium voltage-gated channel alpha subunit 2 | 0.518 | 0.731 | 1.00 |
|
phenotype | 0.200 | None | 0.944 | 0 | 4 | 2004 | 2019 | ||||||||
|
NIPBL cohesin loading factor | 0.521 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0 | 1 |